Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Journal for Immunotherapy of Cancer|August 2, 2020
Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinomaSara Bedrose, Kevin Charles Miller, Lina Altameemi, et al.The Journal of Clinical Endocrinology and Metabolism|August 12, 2024
Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid CancerBhavana Konda, Eric J Sherman, Erminia Massarelli, et al.The Lancet. Diabetes & Endocrinology|May 3, 2025
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statementSophie Leboulleux, Laura Boucai, Naifa Busaidy, et al.Proceedings of the National Academy of Sciences of the United States of America|June 7, 2017
Transposon mutagenesis identifies chromatin modifiers cooperating with <i>Ras</i> in thyroid tumorigenesis and detects <i>ATXN7</i> as a cancer geneCristina Montero-Conde, Luis J Leandro-Garcia, Xu Chen, et al.Practical Radiation Oncology|October 29, 2021
Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive ChemoradiotherapyRobert W Gao, Robert L Foote, Yolanda I Garces, et al.Pancreas|May 3, 2021
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and ParagangliomaLauren Fishbein, Jaydira Del Rivero, Tobias Else, et al.Thyroid : Official Journal of the American Thyroid Association|October 10, 2019
A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid CancerAshish V Chintakuntlawar, Jun Yin, Robert L Foote, et al.Endocrine|September 11, 2023
Clinician feedback using a shared decision-making tool for the evaluation of patients with thyroid nodules-an observational studyNaykky Singh Ospina, Chandani Patel Chavez, Eddison Godinez Leiva, et al.JAMA Otolaryngology-- Head & Neck Surgery|January 11, 2024
Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma: A Review and Multidisciplinary 2023 UpdateLindsay A Bischoff, Ian Ganly, Laura Fugazzola, et al.The Journal of Clinical Endocrinology and Metabolism|October 14, 2017
Survival in Response to Multimodal Therapy in Anaplastic Thyroid CancerNaiyarat Prasongsook, Aditi Kumar, Ashish V Chintakuntlawar, et al.Pageof 6